home / stock / revbw / revbw quote
Last: | $0.0127 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $0.0127 |
High: | $0 |
Low: | $0 |
Volume: | 4 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0127 | $0 | $0.0127 | $0 | $0 | 4 | 07-26-2024 |
$0.0127 | $0.0107 | $0.0127 | $0.0128 | $0.0107 | 7,350 | 07-24-2024 |
$0.0128 | $0.0152 | $0.0128 | $0.0152 | $0.0128 | 3,483 | 07-23-2024 |
$0.0148 | $0 | $0.0148 | $0 | $0 | 4 | 07-22-2024 |
$0.0148 | $0.011 | $0.0148 | $0.0148 | $0.011 | 204 | 07-19-2024 |
$0.0149 | $0.0152 | $0.0149 | $0.0152 | $0.0111 | 11,000 | 07-18-2024 |
$0.0144 | $0.0108 | $0.0144 | $0.0144 | $0.0108 | 2,709 | 07-17-2024 |
$0.014362 | $0.014362 | $0.014362 | $0.014362 | $0.014362 | 1,000 | 07-16-2024 |
$0.0139 | $0.011 | $0.0139 | $0.014 | $0.011 | 7,251 | 07-15-2024 |
$0.011949 | $0.0139 | $0.011949 | $0.0177 | $0.0114 | 57,604 | 07-12-2024 |
$0.014391 | $0.01381 | $0.014391 | $0.014391 | $0.01381 | 2,685 | 07-11-2024 |
$0.017799 | $0.017799 | $0.017799 | $0.017799 | $0.017799 | 251 | 07-10-2024 |
$0.0177 | $0.013701 | $0.0177 | $0.0177 | $0.0137 | 8,674 | 07-09-2024 |
$0.0188 | $0.0198 | $0.0188 | $0.0247 | $0.0183 | 18,013 | 07-08-2024 |
$0.0163 | $0.0163 | $0.0163 | $0.0163 | $0.0163 | 2,793 | 07-04-2024 |
$0.0163 | $0.0163 | $0.0163 | $0.0163 | $0.0163 | 2,793 | 07-03-2024 |
$0.0171 | $0.0172 | $0.0171 | $0.025 | $0.0171 | 114,703 | 07-02-2024 |
$0.02 | $0.02 | $0.02 | $0.02 | $0.019899 | 5,628 | 07-01-2024 |
$0.02 | $0.022 | $0.02 | $0.022 | $0.02 | 19,188 | 06-28-2024 |
$0.0167 | $0 | $0.0167 | $0 | $0 | 1,122 | 06-27-2024 |
News, Short Squeeze, Breakout and More Instantly...
Revelation Biosciences Inc Wt Exp 12/29/2026 Company Name:
REVBW Stock Symbol:
NASDAQ Market:
Revelation Biosciences Inc Wt Exp 12/29/2026 Website:
SAN DIEGO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatme...
SAN DIEGO, July 29, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic-based therapies for the prevention and treatment of d...
SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic-based therapies for the prevention and treatment of d...